BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Maphanga TG, Naicker SD, Kwenda S, Muñoz JF, van Schalkwyk E, Wadula J, Nana T, Ismail A, Coetzee J, Govind C, Mtshali PS, Mpembe RS, Govender NP; for GERMS-SA. In Vitro Antifungal Resistance of Candida auris Isolates from Bloodstream Infections, South Africa. Antimicrob Agents Chemother 2021;65:e0051721. [PMID: 34228535 DOI: 10.1128/AAC.00517-21] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Tsai Y, Lu P, Tang H, Huang C, Hung W, Tseng Y, Lee K, Lin S. The First Invasive Candida auris Infection in Taiwan. Emerging Microbes & Infections. [DOI: 10.1080/22221751.2022.2100280] [Reference Citation Analysis]
2 Burrack LS, Todd RT, Soisangwan N, Wiederhold NP, Selmecki A, Heitman J. Genomic Diversity across Candida auris Clinical Isolates Shapes Rapid Development of Antifungal Resistance In Vitro and In Vivo. mBio. [DOI: 10.1128/mbio.00842-22] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Jacobs SE, Jacobs JL, Dennis EK, Taimur S, Rana M, Patel D, Gitman M, Patel G, Schaefer S, Iyer K, Moon J, Adams V, Lerner P, Walsh TJ, Zhu Y, Anower MR, Vaidya MM, Chaturvedi S, Chaturvedi V. Candida auris Pan-Drug-Resistant to Four Classes of Antifungal Agents. Antimicrob Agents Chemother 2022;:e0005322. [PMID: 35770999 DOI: 10.1128/aac.00053-22] [Reference Citation Analysis]
4 Narayanan A, Selvakumar P, Siddharthan R, Sanyal K. ClaID: a Rapid Method of Clade-Level Identification of the Multidrug Resistant Human Fungal Pathogen Candida auris. Microbiol Spectr 2022;:e0063422. [PMID: 35343775 DOI: 10.1128/spectrum.00634-22] [Reference Citation Analysis]
5 Li J, Coste AT, Bachmann D, Sanglard D, Lamoth F. Deciphering the Mrr1/Mdr1 Pathway in Azole Resistance of Candida auris. Antimicrob Agents Chemother 2022;:e0006722. [PMID: 35343781 DOI: 10.1128/aac.00067-22] [Reference Citation Analysis]
6 Espinel-ingroff A. Commercial Methods for Antifungal Susceptibility Testing of Yeasts: Strengths and Limitations as Predictors of Resistance. JoF 2022;8:309. [DOI: 10.3390/jof8030309] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Maphanga TG, Mpembe RS, Naicker SD, Govender NP; for GERMS-SA. In Vitro Antifungal Activity of Manogepix and Other Antifungal Agents against South African Candida auris Isolates from Bloodstream Infections. Microbiol Spectr 2022;10:e0171721. [PMID: 35196811 DOI: 10.1128/spectrum.01717-21] [Reference Citation Analysis]
8 Rybak JM, Barker KS, Muñoz JF, Parker JE, Ahmad S, Mokaddas E, Abdullah A, Elhagracy RS, Kelly SL, Cuomo CA, Rogers PD. In vivo emergence of high-level resistance during treatment reveals the first identified mechanism of amphotericin B resistance in Candida auris. Clin Microbiol Infect 2021:S1198-743X(21)00677-7. [PMID: 34915074 DOI: 10.1016/j.cmi.2021.11.024] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
9 Carolus H, Jacobs S, Lobo Romero C, Deparis Q, Cuomo CA, Meis JF, Van Dijck P. Diagnostic Allele-Specific PCR for the Identification of Candida auris Clades. J Fungi (Basel) 2021;7:754. [PMID: 34575792 DOI: 10.3390/jof7090754] [Reference Citation Analysis]